REMEDY : BNSSG referral pathways & Joint Formulary


Home > Formulary : Paediatric > Paediatric Chapters > 5. Infections >

BNSSG Paediatric Joint Formulary

5.7 Treatment of COVID-19

Last edited: 25-06-2024

5.7.1 COVID-19

Neutralising monoclonal antibodies (nMABs) in the treatment of COVID-19

Sotrovimab (Xevudy®) (TLS Red)

  • For patients over the age of 12 as per:
    • NICE TA878 Casirivimab plus imdevimab, nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19
    • For use as per NHS Clinical Commissioning Policy. See CAS Alert documents here

 

Antivirals in the treatment of COVID-19

Remdesivir (TLS Red)

  • NICE TA971 Remdesivir for treating COVID-19
  • For use as per NHS Clinical Commissioning Policy. See CAS Alert documents here